Precision cardiology is a vision of a health-care approach that identifies the optimal course of care for each patient. Although precision cardiology is still in its nascent stage, new approaches and methodologies are being developed to achieve this goal and to overcome technical and implementation barriers. In 2018, several high-impact studies made progress in this direction.
Key advances
-
The utility of genomic data to risk-stratify individuals susceptible to coronary artery disease (CAD) has been demonstrated in a study of 480,000 adults, underscoring the importance of identifying the heritable component of CAD risk early in life2.
-
The mSToPS trial demonstrated that a home-based, self-applied, wearable electrocardiogram patch could improve diagnosis of atrial fibrillation (AF) and reduce the risk of stroke compared with routine care; similarly, early detection of AF could be achieved by a commercially available smart watch coupled with a deep neural network4,5.
-
The feasibility of using a personalized virtual-heart methodology to determine the optimal ablation targets for infarct-related ventricular tachycardia and to directly guide patient treatment has been demonstrated6.
-
Computational modelling has been utilized to guide tissue-engineering of cardiac valves that uses patient cells, helping to overcome the limitations of earlier engineered valves8.
-
The concept of utilizing individualized, 3D-printed occluders for the left atrial appendage has been proven, bringing us a step closer to the fabrication of durable, personalized cardiovascular implants9.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Patient-centered empirical research on ethically relevant psychosocial and cultural aspects of cochlear, glaucoma and cardiovascular implants – a scoping review
BMC Medical Ethics Open Access 28 August 2023
-
Photoplethysmography based atrial fibrillation detection: a review
npj Digital Medicine Open Access 10 January 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fishman, G. I. et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 122, 2335–2348 (2010).
Inouye, M. et al. Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. J. Am. Coll. Cardiol. 72, 1883–1893 (2018).
Andrade, J., Khairy, P., Dobrev, D. & Nattel, S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ. Res. 114, 1453–1468 (2014).
Steinhubl, S. R. et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA 320, 146–155 (2018).
Tison, G. H. et al. Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiol. 3, 409–416 (2018).
Prakosa, A. et al. Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia. Nat. Biomed. Eng. 2, 732 (2018).
Yacoub, M. H. & Takkenberg, J. J. Will heart valve tissue engineering change the world? Nat. Clin. Pract. Cardiovasc. Med. 2, 60–61 (2005).
Emmert, M. Y. et al. Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model. Sci. Transl Med. 10, eaan4587 (2018).
Robinson, S. S. et al. Patient-specific design of a soft occluder for the left atrial appendage. Nat. Biomed. Eng. 2, 8 (2018).
Yu, C. M. et al. Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation. Nat. Rev. Cardiol. 10, 707–722 (2013).
Acknowledgements
N.T. acknowledges funding from the NIH (PD1 HL123271, R01 HL126802 and U01 HL141074) and a grant from Foundation Leducq. N.T. is grateful to Ashish Doshi (Johns Hopkins University, USA) for help in preparing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
N.T. is a founder of CardioSolv, holds an equity ownership interest in the company and acts as its Chief Scientific Officer.
Rights and permissions
About this article
Cite this article
Trayanova, N. From genetics to smart watches: developments in precision cardiology. Nat Rev Cardiol 16, 72–73 (2019). https://doi.org/10.1038/s41569-018-0149-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-018-0149-y
This article is cited by
-
Patient-centered empirical research on ethically relevant psychosocial and cultural aspects of cochlear, glaucoma and cardiovascular implants – a scoping review
BMC Medical Ethics (2023)
-
The early warning research on nursing care of stroke patients with intelligent wearable devices under COVID-19
Personal and Ubiquitous Computing (2023)
-
Photoplethysmography based atrial fibrillation detection: a review
npj Digital Medicine (2020)